137 related articles for article (PubMed ID: 16242454)
21. Thrombomodulin activity on human saphenous vein grafts prepared for coronary artery bypass.
Cook JM; Cook CD; Marlar R; Solis MM; Fink L; Eidt JF
J Vasc Surg; 1991 Aug; 14(2):147-51. PubMed ID: 1650405
[TBL] [Abstract][Full Text] [Related]
22. Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow.
Golledge J; Turner RJ; Harley SL; Springall DR; Powell JT
J Clin Invest; 1997 Jun; 99(11):2719-26. PubMed ID: 9169502
[TBL] [Abstract][Full Text] [Related]
23. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression.
Lindemann S; Sharafi M; Spiecker M; Buerke M; Fisch A; Grosser T; Veit K; Gierer C; Ibe W; Meyer J; Darius H
Thromb Res; 2000 Feb; 97(3):113-23. PubMed ID: 10680642
[TBL] [Abstract][Full Text] [Related]
24. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture.
Crook MF; Newby AC; Southgate KM
Atherosclerosis; 2000 May; 150(1):33-41. PubMed ID: 10781633
[TBL] [Abstract][Full Text] [Related]
25. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a 'no-touch' technique.
Tsui JC; Souza DS; Filbey D; Bomfim V; Dashwood MR
Br J Surg; 2001 Sep; 88(9):1209-15. PubMed ID: 11531869
[TBL] [Abstract][Full Text] [Related]
26. Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury.
Zhu M; Chen J; Yin H; Jiang H; Wen M; Miao C
Vascul Pharmacol; 2014; 61(2-3):72-9. PubMed ID: 24732179
[TBL] [Abstract][Full Text] [Related]
27. Influence of pressure on the endothelium of the saphenous vein coronary artery bypass graft.
Dumanski A; Sopel M; Pelczar M; Szłapka M; Kustrzycki W; Zabel M
In Vivo; 2007; 21(5):785-9. PubMed ID: 18019412
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of three nitric oxide synthase isoforms in human saphenous vein exposed to different degrees of distension pressures.
Viaro F; Capellini VK; Celotto AC; Carlotti CG; Rodrigues AJ; Reis GS; Augusto Vdos S; Evora PR
Cardiovasc Pathol; 2010; 19(6):e211-20. PubMed ID: 20060328
[TBL] [Abstract][Full Text] [Related]
29. The effect of different β-blockers on vascular graft nitric oxide levels: comparison of nebivolol versus metoprolol.
Bayar E; Ilhan G; Furat C; Atik C; Arslanoglu Y; Kuran C; Ozpak B; Durakoglugil ME
Eur J Vasc Endovasc Surg; 2014 Feb; 47(2):204-8. PubMed ID: 24309401
[TBL] [Abstract][Full Text] [Related]
30. Expression of endothelin-1 and constitutional nitric oxide synthase messenger RNA in saphenous vein endothelial cells exposed to arterial flow shear stress.
Zhu ZG; Li HH; Zhang BR
Ann Thorac Surg; 1997 Nov; 64(5):1333-8. PubMed ID: 9386700
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production.
Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
J Thorac Cardiovasc Surg; 2006 Oct; 132(4):925-32. PubMed ID: 17000306
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts.
Chester AH; Morrison KJ; Yacoub MH
Ann Thorac Surg; 1998 Jun; 65(6):1685-9. PubMed ID: 9647082
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of ischemia/reperfusion injury in rats by the anti-inflammatory action of resveratrol.
Das S; Falchi M; Bertelli A; Maulik N; Das DK
Arzneimittelforschung; 2006; 56(10):700-6. PubMed ID: 17225566
[TBL] [Abstract][Full Text] [Related]
34. Intercellular and vascular cell adhesion molecule levels in endoscopic and open saphenous vein harvesting for coronary artery bypass surgery.
Alrawi SJ; Samee M; Raju R; Shirazian D; Acinapura AJ; Cunningham JN
Heart Surg Forum; 2000; 3(3):241-5. PubMed ID: 11074980
[TBL] [Abstract][Full Text] [Related]
35. Expression of neuronal nitric oxide synthase in the internal thoracic artery and saphenous vein.
Webb GD; Lim LH; Oh VM; El Oakley R; Lee CN; Wong PS; Aye WM; Chan ES; Moore PK
J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1131-6. PubMed ID: 17059934
[TBL] [Abstract][Full Text] [Related]
36. Late outcomes after radial artery versus saphenous vein grafting during reoperative coronary artery bypass surgery.
Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah AS; Engoren M; Habib RH
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1511-1518.e4. PubMed ID: 19818456
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats.
Abdallah DM; Ismael NR
Can J Physiol Pharmacol; 2011 Nov; 89(11):811-8. PubMed ID: 22029500
[TBL] [Abstract][Full Text] [Related]
38. Difference in acetylcholine-induced nitric oxide release of arterial and venous grafts in patients after coronary bypass operations.
Nishioka H; Kitamura S; Kameda Y; Taniguchi S; Kawata T; Mizuguchi K
J Thorac Cardiovasc Surg; 1998 Sep; 116(3):454-9. PubMed ID: 9731787
[TBL] [Abstract][Full Text] [Related]
39. Effective silencing of adhesion molecules on venous endothelial cells for protection of venous bypass grafts.
Walker T; Müller I; Raabe C; Nohe B; Zanke C; Ziemer G; Wendel HP
Eur J Cardiothorac Surg; 2011 Nov; 40(5):1241-7. PubMed ID: 21429759
[TBL] [Abstract][Full Text] [Related]
40. Transit-time blood flow measurements in sequential saphenous coronary artery bypass grafts.
Nordgaard H; Vitale N; Haaverstad R
Ann Thorac Surg; 2009 May; 87(5):1409-15. PubMed ID: 19379875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]